Skip to main content
Michael Trauner, MD, Dermatology, Ventura, CA, Community Memorial Hospital

MichaelATraunerMD

Dermatology Ventura, CA

Cosmetic Dermatology, Dermatologic Surgery

Premier Dermatology & Mohs Surgery Center

Dr. Trauner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Trauner's full profile

Already have an account?

Summary

  • Dr. Michael Trauner is a dermatologist in Ventura, CA. He received his medical degree from Duke University School of Medicine and has been in practice 20 years. He specializes in cosmetic dermatology and dermatologic surgery and is experienced in dermatologic surgery, cosmetic dermatology, and Mohs micrographic surgery.

Education & Training

  • University of California Davis Health
    University of California Davis HealthResidency, Dermatology, 1997 - 2000
  • Kaiser Permanente Northern California (Santa Clara)
    Kaiser Permanente Northern California (Santa Clara)Internship, Internal Medicine, 1994 - 1995
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - 2023
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FAAD) American Academy of Dermatology
  • Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Saving Your Skin: How to Read Sunscreen Labels
    Saving Your Skin: How to Read Sunscreen LabelsJune 25th, 2018
  • NUDCA Analog Shows Promise in NAFLD
    NUDCA Analog Shows Promise in NAFLDJuly 29th, 2019
  • Gilead's FXR Drug Posts Positive Phase 2 Data in Rare Liver Condition
    Gilead's FXR Drug Posts Positive Phase 2 Data in Rare Liver ConditionNovember 9th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations